('Xeros", the "Company" or the "Group")
Exercise of Warrants, Issue of Equity
and
Total Voting Rights
Successful warrant process raises c.
Warrants Now Expired
The final exercise date for the Warrants was
Total Voting Rights
Following Admission, the Company's issued share capital will consist of 209,896,852 Ordinary Shares with voting rights, with no shares held in treasury. This figure may therefore be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company's share capital pursuant to (i) the Company's Articles, (ii) the Financial Conduct Authority's Disclosure Guidance and Transparency Rules and/or (iii) the AIM Rules for Companies issued by the
Enquiries
|
|
Tel: 0114 269 9656 |
|
|
Cavendish
|
Tel: 020 7220 0570 |
|
|
Belvedere PR |
Mob: 07715 769 078 Mob: 07967 816 525 |
|
*200,000 Warrants were unable to be issued following the Fundraise in
About Xeros
The traditional wet processing methods used in industrial and domestic laundry and garment manufacturing consume billions of litres of fresh water and large amounts of energy and chemicals, as well as damaging and weakening clothing fibres and creating rising levels of environmental pollution. It is estimated that washing machines contribute 35% of the 171 trillion microplastic particles in the ocean.
A range of actors, including consumers, the media NGOs and regulators are exerting pressure on these industries, with legislative action beginning to be taken.
Xeros' three main technologies, Filtration, Finish, and Care, facilitate garment manufacturers, industrial laundries, domestic washing machine manufacturers and consumers, to reduce their environmental impact, whilst also significantly improving efficiency in the process.
Xeros' model is to generate revenue from licensing its technologies, generating royalties and the sale of consumables. Currently there are 8 agreements in place. The addressable markets in Filtration, Finish and Care are estimated to be valued at
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the